About Phil Febbo

I am a Physician Scientist who joined illumina, inc. as Chief Medical Officer in order to improve human health through molecular insight. Illumina’s sequencing technology has revolutionized medical research and has already started to improve patient care.

For the past 25 years, I have worked at leading institutions throughout the United States, most recently serving for almost 5 years as CMO of Genomic Health. Prior to joining Genomic Health, I served as Professor of Medicine and Urology at the University of California, San Francisco (UCSF), where my laboratory focused on using genomics to understand the biology and clinical behavior of prostate cancer, and my clinical practice focused on genitourinary oncology. While at UCSF, I was co-leader of the Prostate Cancer Program at the Helen Diller Family Comprehensive Cancer Center and the Program Principal Investigator of the Translational Research Program for the Alliance for Clinical Trials in Oncology.

I have a Bachelor of Arts degree in Biology from Dartmouth College, received my M.D. degree at UCSF, and completed my internal medicine residency at the Brigham and Women’s Hospital. After my fellowship in medical oncology at the Dana-Farber Cancer Institute, I was an Attending Physician in the Genitourinary Oncology Center at Dana-Farber, Instructor at Harvard Medical School, and a post-doctoral fellow in Dr. Todd Golub’s laboratory at Dana-Farber, as well as the Whitehead Institute Center for Genomic Research of MIT (now the Broad Institute). In 2004, I moved to Duke University Medical Center’s Institute of Genome Sciences and Policy and I have been a member of the American Society for Clinical Investigation since 2009.